Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$865K Buy
7,334
+613
+9% +$80.4K ﹤0.01% 2077
2025
Q4
$800K Buy
+6,721
New +$765K ﹤0.01% 2101
2025
Q3
Sell
-2,435
Closed -$314K 3697
2025
Q2
$314K Buy
2,435
+663
+37% +$80.7K ﹤0.01% 2694
2025
Q1
$227K Buy
1,772
+156
+10% +$22.4K ﹤0.01% 2894
2024
Q4
$247K Sell
1,616
-61
-4% -$10.3K ﹤0.01% 2811
2024
Q3
$299K Buy
1,677
+46
+3% +$8K ﹤0.01% 2568
2024
Q2
$266K Buy
1,631
+175
+12% +$28.4K ﹤0.01% 2548
2024
Q1
$254K Buy
1,456
+113
+8% +$18.5K ﹤0.01% 2579
2023
Q4
$226K Sell
1,343
-108
-7% -$15.7K ﹤0.01% 2591
2023
Q3
$208K Sell
1,451
-493
-25% -$80.3K ﹤0.01% 2466
2023
Q2
$358K Buy
1,944
+290
+18% +$47.4K ﹤0.01% 1985
2023
Q1
$263K Buy
1,654
+37
+2% +$5.68K ﹤0.01% 2170
2022
Q4
$220K Buy
+1,617
New +$226K ﹤0.01% 2279

Other funds holding NOVT

Mariner's NOVT Position: Q1 2026 in Review

Mariner increased its Novanta (NOVT) stake by 9.1% in Q1 2026, buying an estimated $80.4K and bringing the position to 7,334 shares worth $865K. The position accounts for ﹤0.01% of the portfolio, ranked #2077.

Mariner first reported a position in NOVT in Q4 2022 and has held it in 13 quarters since. 329 funds tracked by Wall St. Rank hold NOVT as of Q1 2026.

  • Mariner held 7,334 shares of Novanta worth $865K as of Q1 2026.
  • Mariner bought 613 Novanta shares in Q1 2026, an estimated $80.4K.
  • Novanta made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #2077 holding.
  • Mariner first reported a position in Novanta in Q4 2022 and has held it in 13 quarters since.
  • 329 funds tracked by Wall St. Rank held Novanta as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.